For Investors
Private access — institutional review only.
The Problem
Current medical AI systems predict — they don’t reason. They find patterns but can’t explain their conclusions. This fundamental limitation prevents adoption in clinical settings where explainability is non-negotiable.
The Shift
Abgrat represents a paradigm shift from prediction to clinical intelligence. We’re building AI that reasons through problems the way expert physicians do, with full transparency at every step.
Market Opportunity
The global clinical decision support market is projected to exceed $2B by 2027. But the real opportunity is capturing the trust of clinical institutions — something current solutions have failed to achieve.
Request Access
Investor materials are available on a private, evaluation basis. We work with investors who understand the healthcare landscape and share our long-term vision.